Atlas Trials

Study With Phage for CF Subjects With Pseudomonas Lung Infection

Clinical trial NCT06998043 · RECRUITING

Trial details

NCT number
NCT06998043
Sponsor
BiomX Ltd
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chronic Pseudomonas Aeruginosa InfectionCystic Fibrosis (CF)
Start date
2025-07-02
Primary completion
2026-03-01
Enrollment
63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.